Cargando…

Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer

BACKGROUND: Type II cancers account for 10% of endometrial cancers but 50% of recurrence. Response rates to chemotherapy at recurrence are poor and better prognostic markers are needed to guide therapy. CD151 is a small transmembrane protein that regulates cell migration and facilitates cancer metas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Voss, M A, Gordon, N, Maloney, S, Ganesan, R, Ludeman, L, McCarthy, K, Gornall, R, Schaller, G, Wei, W, Berditchevski, F, Sundar, S
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101917/ https://www.ncbi.nlm.nih.gov/pubmed/21505452 http://dx.doi.org/10.1038/bjc.2011.80

Ejemplares similares

The Tetraspanin CD151 in Papillomavirus Infection
por: Scheffer, Konstanze D., et al.
Publicado: (2014)

Lack of CD151/integrin α3β1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers
por: Romanska, Hanna M, et al.
Publicado: (2015)

Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia
por: Nankivell, P, et al.
Publicado: (2013)

Clinical significance of CD151 overexpression in subtypes of invasive breast cancer
por: Kwon, M J, et al.
Publicado: (2012)

Kidney failure in mice lacking the tetraspanin CD151
por: Sachs, Norman, et al.
Publicado: (2006)

Tetraspanin-induced death of myeloma cell lines is autophagic and involves increased UPR signalling
por: Zismanov, V, et al.
Publicado: (2009)

Androgen receptors are acquired by healthy postmenopausal endometrial epithelium and their subsequent loss in endometrial cancer is associated with poor survival
por: Kamal, A M, et al.
Publicado: (2016)

Expression of N-acetylglucosaminyltransferase V in endometrial cancer correlates with poor prognosis
por: Yamamoto, E, et al.
Publicado: (2007)

Loss of the cell polarity determinant human Discs-large is a novel molecular marker of nodal involvement and poor prognosis in endometrial cancer
por: Sugihara, Takeru, et al.
Publicado: (2016)

Pair-Box (PAX8) protein-positive expression is associated with poor disease outcome in women with endometrial cancer
por: Mhawech-Fauceglia, P, et al.
Publicado: (2012)

Profiling of the Tetraspanin CD151 Web and Conspiracy of CD151/Integrin β1 Complex in the Progression of Hepatocellular Carcinoma
por: Devbhandari, Ranjan Prasad, et al.
Publicado: (2011)

Integrin-independent support of cancer drug resistance by tetraspanin CD151
por: Hwang, Soonyean, et al.
Publicado: (2019)

Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
por: Kahlert, C, et al.
Publicado: (2009)

Characterization of Integrin–Tetraspanin Adhesion Complexes: Role of Tetraspanins in Integrin Signaling
por: Berditchevski, Fedor, et al.
Publicado: (1999)

Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome
por: Krakstad, C, et al.
Publicado: (2012)

Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151()()
por: Tilghman, Jessica, et al.
Publicado: (2016)

The tetraspanin CD151-ARSA mutant inhibits angiogenesis via the YRSL sequence
por: PENG, DAN, et al.
Publicado: (2013)

The tetraspanin CD151 marks a unique population of activated human T cells
por: Perez, Mildred D., et al.
Publicado: (2020)

Tetraspanin CD151 plays a key role in skin squamous cell carcinoma
por: Li, Qinglin, et al.
Publicado: (2012)

Individualised proteome profiling of human endometrial tumours improves detection of new prognostic markers
por: Attarha, S, et al.
Publicado: (2013)

Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas
por: Bignotti, E, et al.
Publicado: (2008)

Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers
por: Shao, R, et al.
Publicado: (2011)

Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma
por: Hagiwara, S, et al.
Publicado: (2012)

Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients
por: Tangen, Ingvild L, et al.
Publicado: (2017)

Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer
por: Hussain, S A, et al.
Publicado: (2007)

Role of CD151, A tetraspanin, in porcine reproductive and respiratory syndrome virus infection
por: Shanmukhappa, Kumar, et al.
Publicado: (2007)

[Corrigendum] The tetraspanin CD151‑ARSA mutant inhibits angiogenesis via the YRSL sequence
por: Peng, Dan, et al.
Publicado: (2023)

TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer
por: Knight, J F, et al.
Publicado: (2008)

Role of lymphangiogenesis in epithelial ovarian cancer
por: Sundar, S S, et al.
Publicado: (2006)

CD47 overexpression is associated with decreased neutrophil apoptosis/phagocytosis and poor prognosis in non-small-cell lung cancer patients
por: Barrera, Lourdes, et al.
Publicado: (2017)

Tetraspanin CD151 as an emerging potential poor prognostic factor across solid tumors: a systematic review and meta-analysis
por: Zeng, Ping, et al.
Publicado: (2016)

RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas
por: Deb, S, et al.
Publicado: (2014)

GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma
por: Xue, Y, et al.
Publicado: (2014)

HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
por: Ørbo, Anne, et al.
Publicado: (2016)

Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival
por: Cummings, M, et al.
Publicado: (2015)

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients
por: Bignotti, E, et al.
Publicado: (2011)

Two-marker protein profile predicts poor prognosis in patients with early rectal cancer
por: Zlobec, I, et al.
Publicado: (2008)

Impact of genomic stability on protein expression in endometrioid endometrial cancer
por: Lomnytska, M I, et al.
Publicado: (2012)

A clinically applicable molecular-based classification for endometrial cancers
por: Talhouk, A, et al.
Publicado: (2015)

Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parameters
por: Versluis, M A, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8p40ragnm5gihpg33b48h1l27q